Search intent hub
Longevity Peptides
A hype-resistant guide to longevity claims, biomarkers, and what evidence is missing.
Concise answer
What searchers should know
Most longevity peptide claims are not supported by long-term human outcome trials. Biomarker changes are not proof of longer life or disease prevention.
Guide note
The biomarker trap
Changing GH, IGF-1, inflammation markers, or skin markers is not the same as proving longer life, fewer diseases, or better function.
Guide note
Higher evidence bar
Longevity claims should require long-term human safety and clinical outcome evidence, not anecdotes or animal-only studies.
Guide note
Compliant language
PeptideWars avoids phrases such as reverse aging, age reversal, or guaranteed rejuvenation.
Profiles
Peptides in This Hub
GHK-Cu
A copper-binding tripeptide discussed in skin biology, cosmetic formulations, and wound-healing research.
CJC-1295
An investigational long-acting GHRH analog studied for growth hormone and IGF-1 signaling.
Ipamorelin
A selective growth hormone secretagogue studied in early human pharmacology and gastrointestinal motility contexts.
Battles
Related Comparisons
Common Questions
What peptide reverses aging?
PeptideWars does not identify any peptide as proven to reverse aging.
Are GH secretagogues longevity tools?
Not on current evidence. Hormone-axis compounds can carry risks and require clinician oversight.